IIR recognizes the contributions of these Sponsors.
If you would like to learn more about sponsorship opportunities with us, click here.
Gold Sponsors
http://www.cardinal.comCardinal Health is the global leader in outsourcing, serving the pharmaceutical and biotechnology industry. With seven decades of experience and over 1,000 patents and patent applications, Cardinal Health brings its customers innovative expertise throughout a drug's development, launch and entire life cycle. And Cardinal Health offers the broadest range of dose form manufacturing options in the industry-from traditional and proprietary oral forms to sterile parenterals and topicals-in 40 facilities on five continents. What makes Cardinal Health unique in pharmaceutical outsourcing is the services that we offer: formulation development, analytical and stability studies, clinical and commercial supplies manufacturing and packaging, contract sales, and life cycle maximization strategies.
Elan provides a broad range of creative product optimization approaches to clients including formulation development, scale-up and manufacturing. Technologies include NanoCrystal® Technology to enhance dissolution of poorly soluble drugs which can be incorporated into a variety of dosage forms and Controlled Release technologies which customize release profiles for range oral dosage forms.http://www.elan.com/EDT
Eurand is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies. Eurand’s technology platforms include – bioavailability enhancement of poorly soluble drugs, customized drug release profiles, taste-making and fast-dissolving oral disintegrating tablet (ODT) formulations, and drug conjugation – enabling a variety of delivery alternatives for drugs in several therapeutic areas. Visit us at our website.http://www.eurand.com
Nastech is a biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products based on our proprietary molecular biology-based drug delivery technology. Nastech's proprietary technologies focus on the intranasal delivery of compounds ranging from small molecules to peptides and complex proteins. Intranasal drug delivery may lead to greater drug efficacy, speed of action, safety and patient compliance. Nastech offers partners a full spectrum of development capabilities, from early stage formulation development to the management of clinical trials and regulatory filings, as well as the manufacturing of clinical and commercial product.http://www.nastech.comAssociate Sponsors
Altea Therapeutics is a private specialty pharmaceutical company developing and commercializing pharmaceutical products based on a new class of transdermal patches that deliver therapeutic levels of water-soluble small drugs, proteins and carbohydrates in a convenient, painless and cost-effective manner.http://www.alteatherapeutics.com
Aveva Drug Delivery Systems offers a full range of Transdermal patch products for license along with a full compliment of R&D capabilities to produce transdermal drug delivery systems that fortify R&D pipelines and maximize product life cycles. Aveva is one of the world’s largest manufacturers of, and a pioneer in, transdermal drug delivery systems with a 20-year history of providing value to pharmaceutical partners with fully integrated, controlled-release transdermal products that fulfill unmet market needs.http://www.avevadds.com
Baxter's BioPharma Solutions business offers contract services and technologies for parenteral drugs. Proprietary technologies include: NANOEDGE dispersion and PROMAXX microsphere formulation technologies and enhanced packaging. Contract services include: development and manufacturing of API, form/fill/finish into syringes, vials and cartridges, lyophilization and cytotoxics manufacturing.http://www.baxterbiopharmasolutions.com
Brookwood - Genzyme Pharmaceuticals Collaboration
Brookwood Pharmaceuticals
Brookwood Pharmaceuticals, Inc., a SurModics company – a drug delivery company focused on product development, manufacturing and biomaterials. Technologies: Long-acting parenterals (microparticles, nanoparticles, and injectable solid implants), Systemic and Local Delivery (small molecules, peptides, proteins, antibodies and nucleic acids), Design for Peptide DeliverySM www.d4pd.com, NLCsTM (Nanostructured Lipid Carriers), Lakeshore BiomaterialsTM (in-stock and custom biodegradable polymers). Services: Partnered programs (feasibility studies, product development and optimization), process scale up and engineering, Clinical trial and commercial manufacturing.Genzyme Pharmaceuticals
Genzyme Pharmaceuticals, a business unit of Genzyme Corporation, is an integrated resource of value-added technologies, custom manufacturing and strategic relationships focused in the lipid, peptide, amino acid derivative and drug delivery markets, including oligonucleotide delivery. Technologies: LipoBridge® LipoMaskTM, CerenseSM Design for Peptide DeliverySM www.d4pd.com. Services: Custom Manufacturing – API’s, complex organics, intermediates..jpg "Davidson, Davidson and Kappel")
Davidson, Davidson and Kappel
Davidson, Davidson & Kappel, LLC is a full-service intellectual property law firm with offices in New York City. The firm has a particularly strong emphasis in the pharmaceutical arts. Attorneys at DDK have written highly valuable pharmaceutical patents, and have litigated and opined on others. At DDK, we pride ourselves on our ability to provide prompt, personal attention to our clients’ intellectual property matters. The protection of intellectual property assets is a critical factor in the success of any technology-oriented business. Our firm provides the counseling and representation necessary to protect the U.S. and international assets of our clients, including patent and trademark procurement, clearance and infringement counseling and analysis; pharmaceutical life cycle management, intellectual property due diligence and transactional counseling; intellectual property licensing; and intellectual property litigation (including Hatch-Waxman). The firm is known for its cutting-edge abilities in drafting patents/patent claims covering pharmaceuticals and biologicals.
DURECT is an emerging specialty pharmaceutical company developing innovative drugs for pain and other chronic diseases, with late-stage development programs including REMOXY®, POSIDUR™, ELADUR™, and TRANSDUR™-Sufentanil. DURECT’s proprietary (oral, transdermal and injectable depot) delivery technologies enable new indications and superior clinical/commercial attributes such as abuse deterrence, improved convenience, compliance, efficacy and safety for small molecule and biologic drugs. For more information, please visithttp://www.durect.com
Fresenius Kabi Deutschland GmbH
Fresenius Kabi is the leader in Infusion Therapy and Clinical Nutrition in Europe and in its most important countries of Latin America and Asia-Pacific. Fresenius Kabi's core product range includes infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as parenteral and enteral nutrition. Furthermore, the company offers medical devices for the application of Infusion Therapy and Clinical Nutrition as well as products for Transfusion Technology. Fresenius Kabi focuses on the treatment and care of critically and chronically ill patients in and outside the hospital. The company has more than 15,000 employees worldwide and a global network of approx. 50 sales organizations and 40 productions sites.http://www.hesylation.com
Morgan Lewis
Morgan Lewis' Life Sciences Practice is one of the largest in the nation, with more then 200 lawyers whose practice and experience are significantly devoted to the life sciences industry. Additionally, we have more than 60 professionals with advanced scientific degrees in life sciences disciplines. For more than two decades, we have developed our practice to "protect the complete life sciences product life cycle," with depth and quality in all important areas: regulatory, transactional, and litigation.
3M Drug Delivery Systems partners with pharmaceutical and biotech companies to team your molecules with our inhalation or transdermal drug delivery technology. 3M offers a full range of feasibility, development and manufacturing capabilities combined with global regulatory expertise and guidance. This depth of resources is one reason why more than 50% of all metered-dose inhalers worldwide and 80% of all transdermal systems in the U.S. utilize 3M drug delivery technology.http://www.mmm.com
Navigant Consulting
Navigant Consulting, Inc. (NYSE: NCI) is a specialized, independent consulting firm providing strategic, financial, operational and quality performance improvement services to healthcare providers, payers and life science companies. Our healthcare professionals include individuals with experience as hospital, health plan, physician group and healthcare finance program executives as well as PhDs, MDs, RNs, RPhs and many other clinical professionals. We combine the expertise of these seasoned professionals with our commitment to work with our clients to deliver successful and sustainable solutions.
http://www.nektar.comNektar Therapeutics is a biopharmaceutical company that develops and commercializes differentiated therapeutics by applying its industry-leading drug delivery technologies and manufacturing expertise to enhance the efficacy, safety and compliance of existing medicines. Nine of Nektar's partnered products are FDA-approved and marketed, including Exubera® (insulin human [rDNA origin]) Inhalation Powder (Pfizer) for Type I and II diabetes. The company's most advanced proprietary product is Amphotericin B Inhalation Powder for the potential prevention of pulmonary fungal infections in patients at risk for aspergillosis due to immunosuppressive therapy.
Vetter Pharma-Fertigung GmbH & Co. KG
Vetter is a worldwide specialist in the aseptic production of FDA-approved pre-filled application systems. We support pharmaceutical and biotech customers from development to launch of new products. Our patented application systems give the customer a competitive edge in global marketshttp://www.vetter-pharma.com